Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MRPL52 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Mrpl52 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL52 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Estradiol affects the expression of MRPL52 mRNA | CTD | PMID:15598610 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MRPL52 mRNA | CTD | PMID:26496021 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL52 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL52 mRNA | CTD | PMID:34747641 | 2-hydroxypropanoic acid | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of MRPL52 mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | MRPL52 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of MRPL52 mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MRPL52 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MRPL52 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of MRPL52 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MRPL52 mRNA | CTD | PMID:36041667 | acrylamide | increases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of MRPL52 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | MRPL52 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MRPL52 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MRPL52 mRNA | CTD | PMID:23724009 | aristolochic acid A | increases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MRPL52 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to MRPL52 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MRPL52 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MRPL52 mRNA | CTD | PMID:27195522 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MRPL52 mRNA and [bisphenol A co-treated with Estradiol] results in decreased expression of MRPL52 mRNA | CTD | PMID:26496021 and PMID:36041667 | bisphenol A | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MRPL52 mRNA and bisphenol A results in decreased expression of MRPL52 protein | CTD | PMID:32981897 and PMID:36232920 | bisphenol A | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MRPL52 mRNA | CTD | PMID:33221593 | bisphenol A | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MRPL52 mRNA | CTD | PMID:28628672 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MRPL52 mRNA | CTD | PMID:25181051 more ... | bisphenol F | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MRPL52 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MRPL52 mRNA | CTD | PMID:36041667 | carbon nanotube | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of MRPL52 mRNA | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MRPL52 mRNA | CTD | PMID:37019170 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of MRPL52 mRNA | CTD | PMID:24386269 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of MRPL52 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MRPL52 mRNA | CTD | PMID:20106945 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of MRPL52 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MRPL52 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MRPL52 mRNA | CTD | PMID:28628672 | dioxygen | multiple interactions | ISO | Mrpl52 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL52 mRNA | CTD | PMID:30529165 | epoxiconazole | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of MRPL52 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Ethanol affects the expression of MRPL52 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Mrpl52 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL52 mRNA | CTD | PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MRPL52 mRNA | CTD | PMID:22061828 | indometacin | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MRPL52 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MRPL52 mRNA | CTD | PMID:28628672 | lipopolysaccharide | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL52 mRNA | CTD | PMID:31059760 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of MRPL52 mRNA | CTD | PMID:24136188 | ozone | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL52 mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MRPL52 mRNA | CTD | PMID:26690555 and PMID:31059760 | paracetamol | multiple interactions | ISO | MRPL52 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL52 mRNA | CTD | PMID:31059760 | rac-lactic acid | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of MRPL52 mRNA | CTD | PMID:30851411 | sunitinib | increases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MRPL52 mRNA | CTD | PMID:31533062 | thalidomide | decreases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of MRPL52 mRNA | CTD | PMID:26217789 | titanium dioxide | decreases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | titanium dioxide analog results in decreased expression of MRPL52 mRNA | CTD | PMID:25111187 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of MRPL52 mRNA | CTD | PMID:22967744 | triptonide | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | triptonide results in increased expression of MRPL52 mRNA | CTD | PMID:33045310 | tungsten | increases expression | ISO | Mrpl52 (Mus musculus) | 6480464 | Tungsten results in increased expression of MRPL52 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Urethane results in decreased expression of MRPL52 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MRPL52 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | MRPL52 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MRPL52 mRNA | CTD | PMID:25979313 | |